Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | -3.42% | -6.46% | -7.84% |
05-22 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
04-22 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.84% | 493M | |
-2.17% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- Transcript : KalVista Pharmaceuticals, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-13-2022 03